Sunday 12 October 2025
Saal 2
03.00 – 05.00 PM
IFSI SIG Global Day:
What is important for patients?
Chair: Sonja Ständer, Germany
Gil Yosipovitch, USA
What is important for patients?
Chair: Sonja Ständer, Germany
Gil Yosipovitch, USA
03.00 – 03.20 PM
Patient organisations
Matthias Augustin, Germany
Matthias Augustin, Germany
03.20 – 03.40 PM
Treat to target criteria in itch
Sonja Ständer, Germany
Sonja Ständer, Germany
03.40 – 04.00 PM
Working towards a modular, validated itch questionnaire
Antoinette van Laarhoven, Netherlands
Antoinette van Laarhoven, Netherlands
04.00 – 04.20 PM
Itch in atopic dermatitis: ethnic differences in the perception and quality of itch
Yozo ishiuji, Japan
Yozo ishiuji, Japan
04.20 – 04.40 PM
Psychological factors in itch
Christina Schut, Germany
Christina Schut, Germany
04.40 – 05.00 PM
All: discussion
05.00 – 05.30 PM
Break
05.30 – 05.50 PM
Opening Ceremony
Elke Weisshaar, Germany
Martin Schmelz, Germany
Elke Weisshaar, Germany
Martin Schmelz, Germany
05.50 – 06.10 PM
Bernhard Lecture
Andreas Kremer, Switzerland
Andreas Kremer, Switzerland
06.15 – 06.40 PM
Kuraishi Lecture
Sarah Ross, USA
Sarah Ross, USA
06.40 – 07.05 PM
SPECIAL INVITED LECTURE
Atopic dermatitis: from the past to the future
Kilian Eyerich, Germany
Atopic dermatitis: from the past to the future
Kilian Eyerich, Germany
07.05 – 07.30 PM
IFSI Awards
07.30
Reception
Monday 13 October 2025
Saal 2
07.00 – 08.00 AM
Satellite Symposium
08.00 – 09.00 AM
Session 1
Plenary:
Plenary:
08.00 – 08.20 AM
Piezo 2: more than mechanically induced itch
Gary Lewin, Germany
Gary Lewin, Germany
08.20 – 08.40 AM
Potassium channels as antipruritic targets
Achim Schmidtko, Germany
Achim Schmidtko, Germany
08.40 – 09.00 AM
Expression of pruriceptors
Jannis Körner, Germany
Jannis Körner, Germany
09.00 – 09.45 AM
Session 2
Young Investigator Council Session
Young Investigator Council Session
The mechanisms of itch contagion
Anastasiia Myronenko, Netherlands
Role of the spinal cord in chronic itch
Miho Shiratori-Hayashi, Japan
Microbe-neuron crosstalk in itch and inflammation Liwen Deng , USA
Periostin in Atopic Dermatitis-Associated Hypersensitivity
Josh Wheeler, USA
ocial anxiety, neuroinflammation and itch in psoriasis
Marcel Schepko, Germany
Experimental profiling of itch patients and anti-pruritic drugs
Silvia Lo Vecchio, Denmark
Anastasiia Myronenko, Netherlands
Role of the spinal cord in chronic itch
Miho Shiratori-Hayashi, Japan
Microbe-neuron crosstalk in itch and inflammation Liwen Deng , USA
Periostin in Atopic Dermatitis-Associated Hypersensitivity
Josh Wheeler, USA
ocial anxiety, neuroinflammation and itch in psoriasis
Marcel Schepko, Germany
Experimental profiling of itch patients and anti-pruritic drugs
Silvia Lo Vecchio, Denmark
10.00 – 10.30 AM
Break
10.30 AM – 12.30 PM
Session 3
Clinics: New treatment concepts in dermatology
Clinics: New treatment concepts in dermatology
10.30 - 10.50 AM
CKD-aP: challenges in clinics and therapy
Jörg Latus, Germany
Jörg Latus, Germany
10.50 - 11.10 AM
Chronic urticaria
Petra Staubach, Germany
Petra Staubach, Germany
11.10 - 11.30 AM
Chronic prurigo
Sonja Ständer, Germany
Sonja Ständer, Germany
11.30 - 11.50 AM
Is chronic itch a public health problem? Epidemiology of chronic itch around the world
Christian Apfelbacher, Germany
Christian Apfelbacher, Germany
11.50 AM - 12.00 PM
Questions & Answers
12.30 - 01.30 PM
LUNCH SYMPOSIUM
Decoding Chronic Itch and More in PN:
Implications of Real-World Data for Clinical Practice
Decoding Chronic Itch and More in PN:
Implications of Real-World Data for Clinical Practice
Prof. Dr. Matthias Augustin, Hamburg
Sarina Elmariah, MD, PhD, MPH, San Francisco
Sarina Elmariah, MD, PhD, MPH, San Francisco
01.30 - 01.45 PM
Break
01.45 - 02.45 PM
Session 4
Plenary session: New drugs and treatment concepts
Plenary session: New drugs and treatment concepts
01.45 - 02.05 PM
A pooled analysis from the RESPONSE and ENHANCE studies
Andreas Kremer, Switzerland
Andreas Kremer, Switzerland
02.05 - 02.25 PM
Results of the APHYPAP clinical study
Christelle Le Gall-Ianotto, France
Christelle Le Gall-Ianotto, France
02.25 - 02.45 PM
Guidelines on itch
Elke Weisshaar, Germany
Claudia Zeidler, Germany
Elke Weisshaar, Germany
Claudia Zeidler, Germany
02.45 - 03.05 PM
Break
03.05 - 04.25 PM
Session 5
Clinics: Unmet needs in pruritus medicine
Clinics: Unmet needs in pruritus medicine
03.05 - 03.25 PM
Neuropathic itch
Sarina Elmariah, USA
Sarina Elmariah, USA
03.25 - 03.45 PM
Registry data
Mathias Augustin, Germany
Mathias Augustin, Germany
03.45 - 04.05 PM
Device based physical therapies
Simon Müller, Switzerland
Simon Müller, Switzerland
04.05 - 04.25 PM
Molecular pharmacological analysis of 15 psychotropic drugs in pruritus modulation:
Implications for atopic dermatitis
Koichi Miyakawa, Japan
Implications for atopic dermatitis
Koichi Miyakawa, Japan
04.25 - 04.40 PM
Break
04.40 - 05.00 PM
IFSI GENERAL ASSEMBLY
05.00 - 05.30 PM
IFSI BOARD MEETING
06.00 PM
SOCIAL AND DINNER
Forum
07.00 – 08.00 AM
Satellite Symposium
09.00 – 09.45 AM
Session 2
Translational aspects of itch
Translational aspects of itch
09.00 – 09.15 AM
Neglected dimensions: Do large language models truly grasp key quality-of-life concerns in chronic itch management?
Ahmet Uğur Atilan, Turkey
Ahmet Uğur Atilan, Turkey
09.15 – 09.30 AM
Broad deployment of the ItchyQuant reveals disparities in care access and follow-up in patients with itch
Rene Chen, USA
Rene Chen, USA
09.30 – 09.45 AM
Dupilumab for itch on prurigo chronica multiformis: A pilot case study
Tsukasa Ugajin, Japan
Tsukasa Ugajin, Japan
10.30 – 12.00 PM
Session 3
Research: Pathobiology of itch
Research: Pathobiology of itch
10.30 – 10.50 AM
Spatial transcriptomics in keloids
Yingrou Tan, Singapore
Yingrou Tan, Singapore
10.50 – 11.10 AM
Itch-specific neuronal clusters and druggable pathways in human DRGs
Tyler Beck, USA
Tyler Beck, USA
11.10 – 11.30 AM
Neurons for itch
Jürgen Solinski, Germany
Jürgen Solinski, Germany
11.30 – 11.50 AM
DRG-neuron expression in atopic dogs
Santosh Mishra, USA
Santosh Mishra, USA
11.50 AM – 12.00 PM
Questions & Answers
12.00 - 12.30 PM
Break
12.30 - 01.30 PM
SATELLITE SYMPOSIUM
03.05 - 04.25 PM
Session 5
Research: Neuroimmune mechanisms
Research: Neuroimmune mechanisms
03.05 - 03.25 PM
The basophil-neuronal axis
Fang Wang, China
Fang Wang, China
03.25 - 03.45 PM
Eosinophils in itch
Ulrike Raap, Germany
Ulrike Raap, Germany
03.45 - 04.05 PM
Epidermal innervation
Dai Hyun Kim, South Korea
Dai Hyun Kim, South Korea
04.05 - 04.25 PM
Neuroimmun mechanisms in Rosacea
Martin Steinhoff, Qatar
Martin Steinhoff, Qatar
04.25 - 04.40 PM
Break
Tuesday 14 October 2025
Saal 2
07.00 – 08.00 AM
Satellite Symposium
08.00 – 09.00 AM
Session 6
Plenary Session
Plenary Session
08.00 – 08.20 AM
Inflammatory itch, a role for cytokines
Mark Hoon, USA
Mark Hoon, USA
08.20 – 08.40 AM
IgE-independent mast cell activation limits itchscratch reflex to preserve barrier integrity
Thomas Plum, Germany
Thomas Plum, Germany
08.40 – 09.00 AM
Mrgpr Channels in itch: from mouse to man
Xinzhong Dong, USA
Xinzhong Dong, USA
09.00 – 09.45 AM
Session 7
Best of German itch CRCs
Best of German itch CRCs
09.00 – 09.15 AM
Correlation of intra-epidermal nerve-fiber innervation depth with itch intensity in AD
Konstantin Agelopoulos, Germany
Konstantin Agelopoulos, Germany
09.15 - 09.30 AM
Integrated clinical-electrical stimulation and RNA-seq identifies a pruritus-specific gene signature in AD vs psoriasis
Peter Olah, Germany
Peter Olah, Germany
09.30 - 09.45 AM
Somatic symptom disorder: higher pruritus intensity, stress and reduced quality of life in chronic pruritus
Stefan Kahnert, Germany
Stefan Kahnert, Germany
10.30 AM - 12.00 PM
Session 8
Clinics: Role of Psychological factors
Clinics: Role of Psychological factors
10.30 AM - 10.50 AM
Psyche and itch: new clinical and molecular findings
Eva Peters, Germany
Eva Peters, Germany
10.50 - 11.10 AM
Patient acceptance and stigmatization in psoriasis
Adam Reich, Poland
Adam Reich, Poland
11.10 - 11.30 AM
Placebo and nocebo effects in itch
Antoinette Laarhoven, Netherlands
Antoinette Laarhoven, Netherlands
11.30 - 11.50 AM
Itch in different age groups: Relationship with psychological factors
Christina Schut, Germany
Christina Schut, Germany
11.50 AM - 12.00 PM
Questions & Answers
12.00 - 12.30 PM
Break
12.30 - 01.30 PM
Satellite Symposium
01.30 - 01.45 PM
Break
01.45 - 02.45 PM
Session 9
Round table Itch and pain encoding
Round table Itch and pain encoding
Discussants
Ethan Lerner (USA), Matthias Ringkamp (USA), Laurent Misery (France)
Ethan Lerner (USA), Matthias Ringkamp (USA), Laurent Misery (France)
01.45 - 02.05 PM
Specificity vs. pattern specificity of experimental models
02.05 - 02.25 PM
Terminology of chronic itch and pain
02.25 - 02.45 PM
Translation of itch encoding from experimental approaches to the clinics
02.45 - 03.45 PM
Session 10
Clinics:
Clinics:
02.45 - 03.05 PM
Chronic pruritus in older adults:
Epidemiology, associated factors, and impact on quality of life
Juliette Bollemeijer, Netherlands
Epidemiology, associated factors, and impact on quality of life
Juliette Bollemeijer, Netherlands
03.05 - 03.25 PM
Itch in malignancy
Jacek Szepietowski, Poland
Jacek Szepietowski, Poland
03.25 - 03.45 PM
Hematological itch
Madeline Caduc, Germany
Madeline Caduc, Germany
03.45 - 04.15 PM
Break
04.00 - 05.15 PM
Session 11
04.15 - 04.35 PM
Future perspectives in basic research of itch
Martin Schmelz, Germany
Martin Schmelz, Germany
04.35 - 04.55 PM
Future perspectives in treatment of itch
Martin Schmelz, Germany
Martin Schmelz, Germany
04.55 - 05.15 PM
Scratching the surface no more: 20 years of IFSI advancing itch research and treatment
Gil Yosipovitch, USA
Gil Yosipovitch, USA
05.15 - 05.30 PM
Prizes & Closing Ceremony
Forum
09.00 – 09.45 AM
Session 7
Clinics: Best of clinical trials
Clinics: Best of clinical trials
09.00 – 09.15 AM
Pooled REMIX-1/-2 phase 3 data:
Early and sustained symptom improvement with remibrutinib in chronic spontaneous urticaria
Martin Metz, Germany
Early and sustained symptom improvement with remibrutinib in chronic spontaneous urticaria
Martin Metz, Germany
09.15 – 09.30 AM
Nemolizumab long-term safety and efficacy up to 104 weeks in the ARCADIA open-label extension study in adolescents and adults with moderate-to-severe atopic dermatitis
Jonathan Silverberg, USA
Jonathan Silverberg, USA
09.30 – 09.45 AM
Lebrikizumab provides skin clearance and itch relief at week 16 and week 52: pooled results from 2 phase 3 studies ADvocate1 and ADvocate2
Diamant Thaçi, Germany
Diamant Thaçi, Germany
09.45 – 10.30 AM
Break
10.30 – 12.00 PM
Session 8
Research: Itch mechanisms in inflammatory skin diseases
Research: Itch mechanisms in inflammatory skin diseases
10.30 – 10.50 AM
Kappa opioids inhibit spinal circuits to suppress itch
Tayler Sheahan, Germany
Tayler Sheahan, Germany
10.50 – 11.10 AM
Novel findings on IL 31
Bernhard Homey, Germany
Bernhard Homey, Germany
11.10 – 11.30 AM
Parabrachial to central amygdala:
central itch neurons
Darya Pavlenko, USA
central itch neurons
Darya Pavlenko, USA
11.30 – 11.50 AM
Itch mechanism in aged skin
Mitsutoshi Tominaga, Japan
Mitsutoshi Tominaga, Japan
11.50 AM – 12.00 PM
Questions & Answers
12.00 - 12.30 PM
Break
12.30 - 01.30 PM
Satellite Symposium
02.45 - 03.45 PM
Session 10
Clinics:
Clinics:
02.45 - 03.05 PM
The many faces of itch in India
Asit Mittal, India
Asit Mittal, India
03.05 - 03.25 PM
Itching in Africa
Grace Mulyowa, Uganda
Grace Mulyowa, Uganda
03.25 - 03.45 PM
Itching in keloids and scars
Hong Liang Tey, Singapore
Hong Liang Tey, Singapore